- Home
- SWTX vs HHH Comparison
SWTX vs HHH Comparison
Compare SWTX & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWTX
- HHH
- Stock Information
- Founded
- SWTX 2017
- HHH 2010
- Country
- SWTX United States
- HHH United States
- Employees
- SWTX N/A
- HHH N/A
- Industry
- SWTX Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- SWTX Health Care
- HHH Real Estate
- Exchange
- SWTX Nasdaq
- HHH Nasdaq
- Market Cap
- SWTX 3.0B
- HHH 3.3B
- IPO Year
- SWTX 2019
- HHH N/A
- Fundamental
- Price
- SWTX $37.92
- HHH $66.35
- Analyst Decision
- SWTX Strong Buy
- HHH Strong Buy
- Analyst Count
- SWTX 5
- HHH 2
- Target Price
- SWTX $72.40
- HHH $82.00
- AVG Volume (30 Days)
- SWTX 2.2M
- HHH 304.8K
- Earning Date
- SWTX 05-01-2025
- HHH 05-07-2025
- Dividend Yield
- SWTX N/A
- HHH 5.29%
- EPS Growth
- SWTX N/A
- HHH N/A
- EPS
- SWTX N/A
- HHH 3.96
- Revenue
- SWTX $191,589,000.00
- HHH $1,750,689,000.00
- Revenue This Year
- SWTX $85.98
- HHH N/A
- Revenue Next Year
- SWTX $69.16
- HHH $45.83
- P/E Ratio
- SWTX N/A
- HHH $11.58
- Revenue Growth
- SWTX 3417.33
- HHH 92.65
- 52 Week Low
- SWTX $28.21
- HHH $56.24
- 52 Week High
- SWTX $62.00
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- SWTX 39.33
- HHH 39.32
- Support Level
- SWTX $36.08
- HHH $64.95
- Resistance Level
- SWTX $38.77
- HHH $66.82
- Average True Range (ATR)
- SWTX 3.21
- HHH 3.10
- MACD
- SWTX -0.17
- HHH -0.28
- Stochastic Oscillator
- SWTX 36.05
- HHH 35.77
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.